NASDAQ: JAZZJazz Pharmaceuticals PLC Stock Ownership - Who owns Jazz Pharmaceuticals?
Insider buying vs selling
Have Jazz Pharmaceuticals PLC insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Bruce C. Cozadd | Chairman CEO | 2025-04-01 | 1,500 | $123.75 | $185.63kSell |
| Patricia Carr | SVP Chief Accounting Officer | 2025-03-10 | 1,140 | $137.81 | $157.10kSell |
| Robert Iannone | EVP Global Head of RD CMO | 2025-03-10 | 2,403 | $138.41 | $332.60kSell |
| Robert Iannone | EVP Global Head of RD CMO | 2025-03-07 | 1,548 | $140.00 | $216.72kSell |
| Robert Iannone | EVP Global Head of RD CMO | 2025-03-07 | 5,532 | $138.21 | $764.58kSell |
| Mary Elizabeth Henderson | SVP Technical Operations | 2025-03-07 | 698 | $138.23 | $96.48kSell |
| Patricia Carr | SVP Chief Accounting Officer | 2025-03-07 | 1,333 | $138.23 | $184.26kSell |
| Neena M. Patil | EVP Chief Legal Officer | 2025-03-05 | 4,088 | $138.95 | $568.03kSell |
| Bruce C. Cozadd | Chairman CEO | 2025-03-05 | 22,251 | $138.95 | $3.09MSell |
| Renee D. Gala | President COO | 2025-03-05 | 5,704 | $138.95 | $792.57kSell |
JAZZ insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when JAZZ insiders and whales buy or sell their stock.
JAZZ Shareholders
What type of owners hold Jazz Pharmaceuticals PLC stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Kkr Group Partnership LP | 50.36% | 30,583,176 | $3.14B | Insider |
| Kkr Jp III LLC | 33.06% | 20,078,838 | $2.06B | Insider |
| Michael W. Michelson | 30.58% | 18,571,250 | $1.91B | Insider |
| Kkr Jp LLC | 30.56% | 18,557,365 | $1.91B | Insider |
| Paul E. Raether | 30.56% | 18,557,365 | $1.91B | Insider |
| Kkr Group Holdings LP | 16.37% | 9,942,946 | $1.02B | Insider |
| William J. Janetschek | 14.12% | 8,577,974 | $881.64M | Insider |
| Kenneth W. Okeefe | 10.65% | 6,470,598 | $665.05M | Insider |
| Vanguard Group Inc | 9.94% | 6,036,183 | $620.40M | Institution |
| Bryan C. Cressey | 9.71% | 5,894,549 | $605.84M | Insider |
JAZZ vs Biotech Stocks
Jazz Pharmaceuticals Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.